Background With the Interferon-γ release assays (IGRA) a new method for the diagnosis of latent tuberculosis infections (LTBI) is available. Due to the lack of a gold standard for the diagnosis of LTBI, the IGRA is compared to the Mantoux Tuberculin Skin Test (TST), which yields discordant results in varying numbers. Therefore we assessed to which extent discordant results can be explained by potential risk factors such as age, BCG vaccination and migration. Methods and Findings In this pooled analysis, two German studies evaluating the Quantiferon-Gold In-Tube test (QFT) by comparison with the TST (RT23 of SSI) were combined and logistic regressions for potential risk factors for TST+/QFT？ as well as THT？/QFT+ discordance were calculated. The analysis comprises 1,033 participants. Discordant results were observed in 15.4%, most of them being TST+/QFT？ combinations. BCG vaccination or migration explained 85.1% of all TST+/QFT？ discordance. Age explained 49.1% of all TST？/QFT+ discordance. Agreement between the two tests was 95.6% in German-born persons younger than 40 years and not BCG-vaccinated. Conclusions After adjustment for potential risk factors for positive or negative TST results, agreement of QFT and TST is excellent with little potential that the TST is more likely to detect old infections than the QFT. In surveillance programs for LTBI in high-income, low TB incidence countries like Germany the QFT is especially suited for persons with BCG vaccination or migrants due to better specificity and in older persons due to its superior sensitivity.
References
[1]
Joshi R, Reingold AL, Menzies D, Pai MTuberculosis among health-care workers in low- and middle-income countries: a systematic review. PLoS Med 3(12): e494. doi:10.1371/journal.pmed. 0030494.
[2]
Seidler A, Nienhaus A, Diel R (2005) Review of epidemiological studies on the occupational risk of tuberculosis in low-incidence areas. Respiration 72(4): 431–446.
[3]
Diel R, Seidler A, Nienhaus A, Rusch-Gerdes S, Niemann S (2005) Occupational risk of tuberculosis transmission in a low incidence area. Respir Res 6(1): 35–45.
[4]
De Vries G, Sebek MM, Lambregts-van Weezenbeek CS (2006) Health-care workers with tuberculosis infected during work. Eur Respir J 28(6): 1216–21.
[5]
Menzies D, Joshi R, Pai M (2007) Risk of tuberculosis infection and disease associated with work in health care settings. Int J Tuberc Lung Dis 11(6): 593–605.
[6]
World Health Organisation WHO report 2008 (2008) Global tuberculosis control: surveillance, planning, financing. Geneva, Switzerland.
[7]
Hill PC, Fox A, Jeffries D, Jackson-Sillah , Lugos MD, et al. (2005) Quantitative T cell assay refects infectious load of Mycobacterium tuberculosis in an endemic case control model. CID 40: 273–78.
[8]
Andersen P, Munk ME, Pollock JM, Doherty TM (2000) Specific immune-based diagnosis of tuberculosis. Lancet 356(9235): 1099–1104.
[9]
Pai M, Riley LW, Colford JM (2004) Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis 4: 761–776.
[10]
Pai M (2005) Alternatives to the tuberculin skin test: interferon-γ assays in the diagnosis of Mycobacterium tuberculosis infection. Indian J. Med. Microbiol 23(3): 151–158.
[11]
Nahid P, Pai M, Hopewell PC (2006) Advances in the diagnosis and treatment of tuberculosis. Proc Am Thorac Soc 3: 103–110.
[12]
Mantoux MC (1912) La voie intradermique en tuberculinthérapie. Press Med 20: 146–48.
[13]
Menzies D, Pai M, Comstock G (2007) Meta-analysis: New tests for the diagnosis of latent tuberculosis infection: Areas of uncertainty and recommendations for research. Ann Intern Med 146: 340–52.
[14]
Mazurek GH, Zajdowicz MJ, Hankinson AL, Costigan DJ, Toney SR, et al. (2007) Detection of mycobacterium tuberculosis infection in Unites States Navy recruits using the tuberculin skin test or whole-blood interferon-γ release assays. CID 45: 826–36.
[15]
Diel R, Loddenkemper R, Meywald-Walter K, Niemann S, Nienhaus A (2008) Predictive Value of a Whole-blood IFN-gamma Assay for the Development of Active TB Disease. Am J Respir Crit Care Med 177: 1164–70.
[16]
Young DB, Perkins MD, Duncan K, Barry CL (2008) Confronting the scientific obstacles to global control of tuberculosis. The Journal of Clinical Investigation 118(4): 1255–1265.
[17]
Lalavani A (2007) Diagnosing tuberculosis infection in the 21st century – New tools to tackle an old enemy, CHEST 131(6): 1898–1906.
[18]
Mori T, Harada N, Higuchi K, Sekiya Y, Uchimura K, et al. (2007) Waning of the specific interferon-gamma response after years of tuberculosis infection. Int J Tuberc lung Dis 11(9): 1021–1025.
[19]
Pai M, Kalantri S, Menzies D (2006) Discordance between tuberculin skin test and interferon-gamma assays. Int J Tuberc lung Dis 10(8): 942–944.
[20]
Diel R, Ernst M, Doscher G, Visuri-Karbe L, Nienhaus A, et al. (2006) Avoiding the effect of BCG vaccination in detecting Mycobacterium tuberculosis infection with a blood test. Eur Respir J 28(1): 16–23.
[21]
Nienhaus A, Schablon A, Siano B, le Bacle C, Diel R (2008) Evaluation of the Interferon-gamma Release Assay in Healthcare Workers. Int Arch Occup Environ Health 81: 295–300.
[22]
Robert Koch Institut (RKI) (2002) Vaccination preventable diseases in Germany until 2000 (Impfpr？ventable Krankheiten in Deutschland bis zum Jahr 2000). Epidem Bulletin 7: 49–57.
[23]
Infuso A, Falzon D (2006) European survey of BCG vaccination policies and surveillance in children, 2005. eurosurveillance 11(1–3): 6–11.
[24]
Hosmer D, Lemeshow S (2000) Applied Logistic Regression. New York, NY: John Wiley & Sons.
[25]
Franken WPJ, Timmermans JT, Prins C, Slootman EJ, Dreverman J, et al. (2007) Comparision of Mantoux and QuantiFERON TB Gold tests for diagnosis of latent tuberculosis infection in army personnel. Clinical and Vaccine Immunology 477–480. doi:10.1128/CVI.00463-06.
[26]
Keskiner R, Erg？nül ？, Demiroglu Z, Eren S, Baykam N, et al. (2004) Risk of tuberculous infection among healthcare workers in a tertiary-care hospital in Ankara, Turkey. Infection Control and Hospital Epidemiology 25(12): 1067–1071.
[27]
Farhat M, Greenaway , Pai M, Menzies D (2006) False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria? Int J Tuberc Lung Dis 10(11): 1192–1204.
[28]
Pai M, Kalantri S, Menzies D (2006) Discordance between tuberculin skin test and interferon-gamma asays. Int J Tuberc Lung Dis 10(8): 942–944.
[29]
Harada N, Nakajima Y, Higuchi K, Sekiya Y, Rothel J, et al. (2006) Screening for Tuberculosis infection using whole-blood interferon-γ and Mantoux testing among Japanese healthcare workers. Infection control and hospital epidemiology 27(5): 442–448.
[30]
Simon and Gutland (1988) The tuberculin test in the clinic – dosage and evaluation. Prax Klin Pneumol (Germany) 42(6): 423–426.
[31]
Hill PC, Brookes RH, Fox A, Jackson-Sillah D, Jeffries J, et al. (2007) Longitudinal Assessment of an ELISPOT Test for Mycobacterium tuberculosis Infection. PLoS Medicine 4(6): 1061–70.
[32]
Diel R, For？bohm M, Loytved G, Haas W, Hauer B, et al. (2007) Recommendations for background studies in tuberculosis. German Central Commitee against Tuberculosis Pneumologie 61: 440–455.
[33]
Barsegian V, Mathias KG, Wrighton-Smith P, Grose-Wilde H, Lindemann M (2008) Prevalence of latent tuberculosis infection in German radiologists. J Hosp Infect. doi:10.1016/j.jhin.2008.02.009.
[34]
World Health Organisation (2008) pp. 1–291. WHO report 2008. Global tuberculosis control: surveillance, planning, financing. Geneva, Switzerland.
[35]
RKI (2002) (Diseases without vaccination in Germany until 2000) Impfpr？ventable Krankheiten in Deutschland bis zum Jahr 2000. Epidemiologisches Bulletin 7: 49–57.
